Rat aortic smooth muscle cells in culture express kallikrein, kininogen, and bradykininase activity
- PMID: 2298924
- PMCID: PMC296465
- DOI: 10.1172/JCI114479
Rat aortic smooth muscle cells in culture express kallikrein, kininogen, and bradykininase activity
Abstract
We have studied rat vascular smooth muscle (VSM) cells in culture for the presence of key elements of the glandular kallikrein-kinin system. Direct radioimmunoassay (RIA) using antiserum against rat urinary kallikrein detected a glandular kallikrein-like enzyme (GKLE) in VSM cells and in media. VSM homogenates and culture media had kininogenase activity, generating kinins from dog kininogen. About half of the GKLE was enzymatically inactive which could be activated with trypsin. Kininogenase activity was inhibited completely by aprotinin but only 20% by soybean trypsin inhibitor (SBTI). Trypsin liberated kinins from homogenates and media, demonstrating that VSM cells contain kininogen. Homogenates and media rapidly degrade bradykinin. GKLE, kininogen, and bradykininase activity were all present in VSM cells grown in defined media that contain no serum, thus eliminating any contamination or artefacts from fetal calf serum in standard culture media. Blood vessels of the rat have been reported to contain GKLE. Our observations indicate that GKLE is synthesized by VSM cells, not deposited from plasma. Furthermore, VSM cells synthesize kininogen and bradykininase(s), the other key elements of the glandular kallikrein-kinin system. Thus it is possible that the system functions as an autocoid mechanism that regulates local vascular tone.
Similar articles
-
Kininogen expression by rat vascular smooth muscle cells: stimulation by lipopolysaccharide and angiotensin II.Biochim Biophys Acta. 1998 Sep 16;1404(3):329-37. doi: 10.1016/s0167-4889(98)00074-3. Biochim Biophys Acta. 1998. PMID: 9739161
-
Kinins contribute to the contractile effects of rat glandular kallikrein on the isolated rat uterus.J Pharmacol Exp Ther. 1989 May;249(2):470-5. J Pharmacol Exp Ther. 1989. PMID: 2724135
-
A kininogenase resembling glandular kallikrein in the rat pituitary pars intermedia.Endocrinology. 1983 Apr;112(4):1194-200. doi: 10.1210/endo-112-4-1194. Endocrinology. 1983. PMID: 6550532
-
[Kallikrein, kininogen and kinin in health and disease].Nihon Rinsho. 1995 Mar;53 Su Pt 2:721-5. Nihon Rinsho. 1995. PMID: 8753343 Review. Japanese. No abstract available.
-
[Kallikrein-kinin system, the kidney and arterial pressure].Nephrologie. 1988;9(1):3-7. Nephrologie. 1988. PMID: 2839786 Review. French.
Cited by
-
Angiotensin II type 2 receptor overexpression activates the vascular kinin system and causes vasodilation.J Clin Invest. 1999 Oct;104(7):925-35. doi: 10.1172/JCI7886. J Clin Invest. 1999. PMID: 10510333 Free PMC article.
-
Bradykinin, insulin, and glycemia responses to exercise performed above and below lactate threshold in individuals with type 2 diabetes.Braz J Med Biol Res. 2017 Sep 12;50(11):e6400. doi: 10.1590/1414-431X20176400. Braz J Med Biol Res. 2017. PMID: 28902927 Free PMC article. Clinical Trial.
-
Molecular aspects of kallikrein and kininogen in the maturing kidney.Pediatr Nephrol. 1993 Oct;7(5):646-51. doi: 10.1007/BF00852573. Pediatr Nephrol. 1993. PMID: 8251340 Review.
-
Kininogen-Nitric Oxide Signaling at Nearby Nonexcited Acupoints after Long-Term Stimulation.JID Innov. 2021 Jun 24;1(3):100038. doi: 10.1016/j.xjidi.2021.100038. eCollection 2021 Sep. JID Innov. 2021. PMID: 34909734 Free PMC article.
-
Endothelial function and bradykinin in humans.Drugs. 1997;54 Suppl 5:42-7. doi: 10.2165/00003495-199700545-00007. Drugs. 1997. PMID: 9429844 Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources